Skip to main content

From the Old Immunitas to the Modern Immunity: Do We Need a New Name for the Immune System?

Buy Article:

$68.00 + tax (Refund Policy)

The Latin term immunitas has come a long way from its first registered use in the context of health and disease two thousand years ago. At first, it was employed mainly by non-physicians and understood as a passive exemption from diseases provoked by gods or demons. After the introduction of variolation and Jenner’s inoculation of cowpox in Europe in the eighteenth century, the term began to be used widely by physicians. Soon after came the demonstration of the germ theory of disease and of the first immune mechanisms of defense, which boosted the use of “immunity”, then understood as a protective battle against the germs. In the twentieth century it became clear that immunity could also provoke side effects in the host, and this was followed by the first criticisms of the outdated term, with little success. In next the following decades, the complexity of immunity increased and the military model was substituted by the self/non-self simile and by the neurological one, both complicated by the attribution of new functions to the immune system, which made the term even more obsolete. At present, immunity is mainly regarded as a complex mechanism of integration of microbes into the cell community of the host. From a conceptual point of view, the “immune” system is now considered a “commune” system, but the terminology has not been challenged: does the old term immunitas hamper the understanding of the new idea of immunity? Would it be appropriate to update it? Our main objective will be to answer these questions on the basis of the historical evolution of the term.

Keywords: Allergy; history of medicine; immune system; immunity; immunological terminology

Document Type: Research Article

Publication date: 01 April 2015

More about this publication?
  • Current Immunology Reviews publishes frontier reviews on all the latest advances in clinical immunology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in clinical immunology.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content